Search results
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation
KTBS Shreveport· 8 hours agoThe FDA’s committee of independent advisers voted unanimously Wednesday to recommend that the agency tell vaccine manufacturers to update the Covid-19 shots for the fall.
Moderna's RSV Vaccine Approved by FDA
Medscape· 5 days agoFor the first time, an mRNA vaccine has been approved for an indication other than COVID-19. The vaccine will join a couple other immunizations currently on the market for respiratory syncytial virus.
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 13 hours agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 2 days agoThe Food and Drug Administration (FDA) has approved mRESVIA, a new vaccine made by Moderna, to help...
What the Options Market Tells Us About Moderna - Moderna (NASDAQ:MRNA)
Benzinga· 16 hours agoModerna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with ...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters· 5 days ago, opens new tab said on Monday their cancer vaccine in combination with blockbuster cancer therapy...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
KEYT 3 Santa Barbara· 2 days agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
NBC New York· 5 days agoModerna and Merck said their experimental vaccine in combination with the therapy Keytruda improved survival and showed durable efficacy in a midstage study ...
ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine
FierceBiotech· 5 days agoAs Keytruda’s 2028 patent cliff looms large, Merck & Co.’s renewed R&D oncology strategy focuses on...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 4 days agoSince mRNA drugs are easily programmable, biotech companies likeModerna are now developing mRNA ...